FDA Drug recall D-0867-2017
LaBri's Body Health Atomic, 60 capsules
- FDA Drug
- Class I
- terminated
- Published 2017-05-31
On 2017-05-31 the FDA classified a Class I recall of LaBri's Body Health Atomic, 60 capsules by Envy Me, citing marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0867-2017 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2017-03-28 |
| Published | 2017-05-31 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Envy Me |
| Distribution | US |
Product
LaBri's Body Health Atomic, 60 capsules
Reason
Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.
Identifiers
| code_info | All lot codes, manufacturing codes and expiration dates. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0867-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.